Vitamin D(3), 25-Hydroxyvitamin D(3), and 1,25-Dihydroxyvitamin D(3) Uptake in Cultured Human Mature Adipocytes.

培养的人类成熟脂肪细胞对维生素D(3)、25-羟基维生素D(3)和1,25-二羟基维生素D(3)的吸收

阅读:11
作者:Uçar Nazlı, Pickering Richard T, Mueller Peter M, Deeney Jude T, Morales Suárez-Varela María, Soriano José Miguel, Holick Michael F
Background/Objectives: Vitamin D(3) is predominantly sequestered in adipose tissue, where it is slowly mobilized under conditions of deficiency in vivo. However, the kinetics of its uptake, release, and interaction with its major metabolites, 25(OH)D(3) and 1,25(OH)(2)D(3), remain poorly understood. Given the close relationship between obesity, low-grade chronic inflammation, and disrupted vitamin D metabolism, a clearer understanding of these dynamics in adipocytes is essential. Thus, we sought to characterize time-dependent uptake and metabolites in differentiated human adipocytes. Methods: Human pre-adipocytes were differentiated in vitro and exposed to either vitamin D(3) and 1,25(OH)(2)D(3) or the combination of vitamin D(3), 25(OH)D(3) and 1,25(OH)(2)D(3). Intracellular concentrations were quantified through HPLC at various time points. A separate efflux experiment assessed vitamin D(3) release under basal and isoproterenol-stimulated conditions using (3)H-vitamin D(3) and scintillation counting. Results: Vitamin D(3) uptake showed a gradual and sustained increase over 96 h, suggesting ongoing accumulation within lipid-rich compartments. In contrast, 25(OH)D(3) and 1,25(OH)(2)D(3) peaked rapidly within the first hour and declined sharply. Isoproterenol stimulation significantly enhanced vitamin D(3) release into the extracellular medium from the adipocytes, indicating increased efflux during lipolytic activation. Conclusions: Adipocytes selectively retain vitamin D(3) while rapidly clearing its hydroxylated forms. These findings highlight the distinct intracellular handling of vitamin D metabolites and suggest that tailored supplementation strategies-particularly in individuals with excess adiposity-may improve bioavailability and metabolic efficacy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。